Title | Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Hanna, M, Dumas, I, Orain, M, Jacob, S, Têtu, B, Sanschagrin, F, Bureau, A, Poirier, B, Diorio, C |
Journal | PLoS One |
Volume | 12 |
Issue | 8 |
Pagination | e0183579 |
Date Published | 2017 |
ISSN | 1932-6203 |
Keywords | Adult, Age Factors, Aging, Breast Neoplasms, Carcinoma, Lobular, Cytokines, Female, Humans, Inflammation, Middle Aged, Postmenopause, Premenopause |
Abstract | Increased levels of pro-inflammatory markers and decreased levels of anti-inflammatory markers in the breast tissue can result in local inflammation. We aimed to investigate whether local inflammation in the breast tissue is associated with age-related lobular involution, a process inversely related to breast cancer risk. Levels of eleven pro- and anti-inflammatory markers were assessed by immunohistochemistry in normal breast tissue obtained from 164 pre- and postmenopausal breast cancer patients. Involution status of the breast (degree of lobular involution and the predominant lobule type) was microscopically assessed in normal breast tissue on hematoxylin-eosin stained mastectomy slides. Multivariate generalized linear models were used to assess the associations. In age-adjusted analyses, higher levels of pro-inflammatory markers IL-6, TNF-α, CRP, COX-2, leptin, SAA1 and IL-8; and anti-inflammatory marker IL-10, were inversely associated with the prevalence of complete lobular involution (all P≤0.04). Higher levels of the pro-inflammatory marker COX-2 were also associated with lower prevalence of predominant type 1/no type 3 lobules in the breast, an indicator of complete involution, in age-adjusted analysis (P = 0.017). Higher tissue levels of inflammatory markers, mainly the pro-inflammatory ones, are associated with less involuted breasts and may consequently be associated with an increased risk of developing breast cancer. |
DOI | 10.1371/journal.pone.0183579 |
Alternate Journal | PLoS ONE |
PubMed ID | 28846716 |
PubMed Central ID | PMC5573208 |